Aescuvest

Aescuvest operates as a European venture capital boutique specializing in Healthtech investments. The firm offers a deal-by-deal investment model, meticulously vetting startups across critical areas such as remote monitoring, advanced diagnostics, personalized medicine, and artificial intelligence applications in healthcare. This rigorous selection process enables investors to co-invest alongside industry specialists in hand-selected opportunities within the evolving health technology landscape.

The company was founded in 2014 by Andreas Kühnemund and Dr. Patrick Pfeffer. As CEO, Dr. Pfeffer, a bioinformatics scientist, was motivated by a core insight: the necessity for a specialized platform to connect innovative healthtech startups with a network of investors seeking curated opportunities. This vision aimed to leverage technological advancements to significantly enhance societal health outcomes.

Aescuvest primarily caters to investors eager to construct individualized portfolios within the healthtech sector, providing access to thoroughly sourced and evaluated investment rounds. The company’s overarching mission is to strategically invest in healthtech solutions that address genuine medical challenges, thereby fostering innovation to shape the future of healthcare. Its long-term vision is firmly rooted in advancing the shift from traditional "sick care" to proactive, technology-driven "healthcare."